Andrew Allen Insider Profile

4 Followers
Andrew Allen, Executive Vice President of Clinical and Pre-Cl... at Clovis Oncology, holds 2.43M shares in Gritstone bio (Ticker: GRTSQ), holds 0.00 shares in Sierra Oncology (Ticker: SRRA), holds 20.56K shares in Epizyme (Ticker: EPZM).
tipranks
Andrew Allen

Andrew Allen
Clovis Oncology (CLVSQ)
Executive Vice President of Clinical and Pre-Cl...

Ranked #42,979 out of 99,218 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+11.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$61K
100.00%
0.00%
A breakdown of Andrew Allen's holdings

Insider Roles

Gritstone bio
(GRTSQ)
President & CEO, Director
Adaptimmune Therapeutics
(ADAP)
Director
Roles that Andrew Allen holds in companies

Most Profitable Insider Trade

Stock:
Gritstone bio
(GRTSQ)
Rating:Informative Sell
Date:May 17, 2024 - Today
Return:+96.10%
The most profitable trade made by Andrew Allen

Andrew Allen's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
CLVSQ
Clovis Oncology
Jan 20, 2015
Uninformative Sell
5.25M
$1.53K
SRRA
Sierra Oncology
Jul 01, 2022
Uninformative Sell
90.75K
$0.00
Gritstone bio
Jun 26, 2024
President & CEO, Director
Uninformative Sell
$60.87K
TCRR
TCR2 Therapeutics
Adaptimmune Therapeutics
Director
EPZM
Epizyme
Jun 15, 2021
Uninformative Buy
$30.22K
List of latest transactions for each holding click on a transaction to see Andrew Allen's performance on stock

Andrew Allen insider profile FAQ

What is the percentage of profitable transactions made by Andrew Allen?
The percentage of profitable transactions made by Andrew Allen is 50%.
    What is the average return per transaction made by Andrew Allen?
    The average return per transaction made by Andrew Allen is 11.60%.
      What stocks does Andrew Allen hold?
      Andrew Allen holds: CLVSQ, SRRA, GRTSQ, TCRR, ADAP, EPZM stocks.
        What was Andrew Allen’s latest transaction?
        Andrew Allen latest transaction was an Uninformative Sell of ―.
          What was Andrew Allen's most profitable transaction?
          Andrew Allen’s most profitable transaction was an Informative Sell of GRTSQ stock on May 17, 2024. The return on the trade was 96.10%.
            What is Andrew Allen's role in Clovis Oncology?
            Andrew Allen's role in Clovis Oncology is Executive Vice President of Clinical and Pre-Cl....
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.